Back to main page

DREAM Module Identification Challenge – Consensus modules

PPI-STRING_Consensus_mod40

Assigned name NA
Network PPI-STRING
Module ID PPI-STRING_Consensus_mod40
Module size 63 genes

Module genes

This module comprises the following genes:

Gene ID Gene Symbol Gene Name
146325

C16orf11 proline rich 35
84290

CAPNS2 calpain small subunit 2
114625

ERMAP erythroblast membrane associated protein (Scianna blood group)
64122

FN3K fructosamine 3 kinase
79672

FN3KRP fructosamine 3 kinase related protein
123722

FSD2 fibronectin type III and SPRY domain containing 2
25801

GCA grancalcin
8520

HAT1 histone acetyltransferase 1
8242

KDM5C lysine demethylase 5C
8284

KDM5D lysine demethylase 5D
4210

MEFV MEFV, pyrin innate immunity regulator
283948

NHLRC4 NHL repeat containing 4
5988

RFPL1 ret finger protein like 1
10739

RFPL2 ret finger protein like 2
10738

RFPL3 ret finger protein like 3
342931

RFPL4A ret finger protein like 4A
442247

RFPL4B ret finger protein like 4B
7732

RNF112 ring finger protein 112
84282

RNF135 ring finger protein 135
54546

RNF186 ring finger protein 186
80352

RNF39 ring finger protein 39
56948

SDR39U1 short chain dehydrogenase/reductase family 39U member 1
344558

SH3RF3 SH3 domain containing ring finger 3
6574

SLC20A1 solute carrier family 20 member 1
6575

SLC20A2 solute carrier family 20 member 2
3431

SP110 SP110 nuclear body protein
11262

SP140 SP140 nuclear body protein
93349

SP140L SP140 nuclear body protein like
10107

TRIM10 tripartite motif containing 10
81559

TRIM11 tripartite motif containing 11
89870

TRIM15 tripartite motif containing 15
51127

TRIM17 tripartite motif containing 17
7726

TRIM26 tripartite motif containing 26
11074

TRIM31 tripartite motif containing 31
53840

TRIM34 tripartite motif containing 34
202658

TRIM39-RPP21 TRIM39-RPP21 readthrough
89122

TRIM4 tripartite motif containing 4
135644

TRIM40 tripartite motif containing 40
90933

TRIM41 tripartite motif containing 41
129868

TRIM43 tripartite motif containing 43
79097

TRIM48 tripartite motif containing 48
57093

TRIM49 tripartite motif containing 49
283257

TRIM49B tripartite motif-containing 51F, pseudogene
642612

TRIM49C tripartite motif containing 49C
84767

TRIM51 tripartite motif-containing 51
84851

TRIM52 tripartite motif containing 52
25893

TRIM58 tripartite motif containing 58
445372

TRIM6-TRIM34 TRIM6-TRIM34 readthrough
166655

TRIM60 tripartite motif containing 60
391712

TRIM61 tripartite motif containing 61
642446

TRIM64B tripartite motif containing 64B
646754

TRIM64C tripartite motif containing 64C
9866

TRIM66 tripartite motif containing 66
55128

TRIM68 tripartite motif containing 68
140691

TRIM69 tripartite motif containing 69
81786

TRIM7 tripartite motif containing 7
493829

TRIM72 tripartite motif containing 72
375593

TRIM73 tripartite motif containing 73
378108

TRIM74 tripartite motif containing 74
339976

TRIML1 tripartite motif family like 1
205860

TRIML2 tripartite motif family like 2
79726

WDR59 WD repeat domain 59
84942

WDR73 WD repeat domain 73

Functional annotation

Modules were tested for enrichment in functional and pathway annotations using two complementary approaches:
1. To select a small number of specific / non-redundant annotations for each module, a regression-based approach was used;
2. To obtain the complete set of enriched annotations, an extension of Fisher’s exact test that takes annotation bias into account was employed (Wallenius’ non-central hypergeometric distribution).

Most specific annotations for this module

Coeff.1P-value.2Source.3Term.4Class.5
1.52e-01 4.50e-05 Reactome Sodium-coupled phosphate cotransporters

Transport of small molecules
1.51e-01 4.50e-05 GO histone demethylase activity (H3-K4 specific)

molecular_function
6.89e-02 6.90e-08 GO negative regulation of viral entry into host cell

biological_process
3.10e-02 9.35e-11 GO transferase activity

molecular_function
2.58e-02 4.11e-06 GO negative regulation of viral release from host cell

biological_process
1.17e-02 1.61e-07 GO protein autoubiquitination

biological_process
1.06e-02 9.78e-10 Reactome Interferon gamma signaling

Immune System
6.61e-03 2.45e-04 GO regulation of androgen receptor signaling pathway

biological_process

1Regression coefficient

2Fisher’s exact test nominal P-value

3Annotation source (Reactome, GO biological process (BP), molecular function (MF) and cellular component (CC))

4GO category or Reactome pathway

5High-level branch of annotation tree

Gene membership

All enriched annotations

Gene Ontology

P-value1 FDR2 Term
1.78e-09 1.28e-06 protein modification by small protein conjugation

3.07e-09 2.15e-06 innate immune response

1.07e-08 6.94e-06 protein ubiquitination

1.51e-08 9.61e-06 regulation of viral release from host cell

2.87e-08 1.76e-05 negative regulation of viral entry into host cell

1.25e-07 6.95e-05 regulation of viral entry into host cell

1.29e-07 7.16e-05 negative regulation of viral process

2.11e-07 1.13e-04 regulation of sequence-specific DNA binding transcription factor activity

2.76e-07 1.45e-04 positive regulation of sequence-specific DNA binding transcription factor activity

4.59e-07 2.32e-04 negative regulation of viral release from host cell

6.99e-07 3.43e-04 response to interferon-gamma

7.94e-07 3.85e-04 regulation of viral life cycle

3.84e-06 1.63e-03 interferon-gamma-mediated signaling pathway

4.82e-06 1.34e-03 ubiquitin-protein transferase activity

6.41e-06 1.74e-03 ubiquitin-like protein transferase activity

9.92e-06 3.84e-03 regulation of viral process

1.58e-05 3.96e-03 inorganic phosphate transmembrane transporter activity

1.65e-05 6.06e-03 cellular response to interferon-gamma

3.92e-05 1.30e-02 histone H3-K4 demethylation

5.57e-05 1.24e-02 sodium-dependent phosphate transmembrane transporter activity


11Nominal enrichment p-value (Wallenius’ noncentral hypergeometric distribution)

2FDR corrected p-value (Benjamini-Hochberg)

Reactome

P-value1 FDR2 Term
1.72e-03 1.87e-01 TRAF6 MEDIATED NFKB ACTIVATION
1.72e-03 1.87e-01 NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10
5.01e-03 4.58e-01 TRAF3 DEPENDENT IRF ACTIVATION PATHWAY
5.64e-03 5.04e-01 INNATE IMMUNE SYSTEM
5.96e-03 5.29e-01 TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES
6.73e-03 5.83e-01 TRAF6 MEDIATED IRF7 ACTIVATION
8.11e-03 6.19e-01 TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES
1.08e-02 7.78e-01 TRAF6 MEDIATED NFKB ACTIVATION
1.08e-02 7.78e-01 NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10
1.32e-02 9.18e-01 THE NLRP3 INFLAMMASOME
1.32e-02 9.18e-01 INFLAMMASOMES
1.45e-02 9.89e-01 INNATE IMMUNE SYSTEM
1.48e-02 1.00e+00 THE NLRP3 INFLAMMASOME
1.69e-02 1.00e+00 NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS
1.76e-02 1.00e+00 NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING
1.78e-02 1.00e+00 TRAF3 DEPENDENT IRF ACTIVATION PATHWAY
2.13e-02 1.00e+00 INFLAMMASOMES
2.16e-02 1.00e+00 NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING
2.39e-02 1.00e+00 SLC MEDIATED TRANSMEMBRANE TRANSPORT
2.46e-02 1.00e+00 NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS

11Nominal enrichment p-value (Wallenius’ noncentral hypergeometric distribution)

2FDR corrected p-value (Benjamini-Hochberg)

Mouse mutant phenotypes

P-value1 FDR2 Term
3.74e-03 1e+00 increased interleukin-18 secretion

3.74e-03 1e+00 decreased interleukin-3 secretion

3.74e-03 1e+00 increased interleukin-1 alpha secretion

5.61e-03 1e+00 increased interleukin-9 secretion

5.61e-03 1e+00 decreased macrophage apoptosis

7.47e-03 1e+00 echinocytosis

7.48e-03 1e+00 pale placenta

7.48e-03 1e+00 enlarged liver sinusoidal spaces

9.33e-03 1e+00 abnormal incisor color

1.12e-02 1e+00 decreased common myeloid progenitor cell number

1.12e-02 1e+00 schistocytosis

1.12e-02 1e+00 joint inflammation

1.30e-02 1e+00 abnormal lung interstitium morphology

1.30e-02 1e+00 abnormal fatty acid level

1.49e-02 1e+00 primary atelectasis

1.49e-02 1e+00 spherocytosis

1.49e-02 1e+00 eyelids fail to open

1.49e-02 1e+00 increased interleukin-12b secretion

1.49e-02 1e+00 arthritis

1.67e-02 1e+00 absent mandible


11Nominal enrichment p-value (Wallenius’ noncentral hypergeometric distribution)

2FDR corrected p-value (Benjamini-Hochberg)


Generated on: Thu Aug 30 17:21:38 2018 - R2HTML